MateraCor

MateraCor, Inc., a startup based in Southern California, is developing new methods to prevent the progression and reverse heart failure. MateraCor's lead product, Transcatheter Myocardial Repair (TCMR), includes an implantable hydrogel and a minimally invasive endocardial delivery system for treating ischemic or non-ischemic heart failure with reduced ejection fraction (HFrEF). TCMR is an investigational device not yet approved for sale.